Regional mRNA changes in brain stem motor neurons from patients with amyotrophic lateral sclerosis

H A Hartmann1, D Y Sun

  • 1Department of Pathology, University of Wisconsin Medical School, Madison 53706.

Molecular and Chemical Neuropathology
|December 1, 1992
PubMed

Insights

Researchers found reduced messenger RNA (mRNA) for neurofilament proteins in amyotrophic lateral sclerosis (ALS) patients. This reduction in mRNA may precede other cellular changes observed in ALS.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron loss.
  • Changes in neurofilament proteins are observed in ALS, but the underlying molecular mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the levels of messenger RNA (mRNA) encoding the midsize neurofilament protein (NFM) in neurons of ALS patients.

Main Methods:

  • An antisense oligonucleotide probe targeting NFM mRNA was synthesized and labeled.
  • In situ hybridization was performed on medulla oblongata tissue sections from ALS patients and normal controls.
  • Slides were analyzed using photographic emulsion and staining to quantify silver grain density.

Main Results:

  • Neurons in the nucleus hypoglossus and nucleus ambiguous of ALS patients showed a significant reduction in silver grains compared to normal controls.
  • This reduction indicates a decrease in NFM mRNA levels in these specific neuronal populations.

Conclusions:

  • The findings suggest a reduction in NFM mRNA precedes other observed molecular changes in ALS.
  • The study highlights a potential early molecular event in ALS pathogenesis but does not distinguish between reduced transcription or increased mRNA decay.